394

Compound name
Dabrafenib
Alt Name
Tafinlar
Compound Image
Dabrafenib.png
SMILES
CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F
Brutto
C23H20F3N5O2S2
InChI
InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)
InChI Key
BFSMGDJOXZAERB-UHFFFAOYSA-N
Approval Jurisdiction
2013 FDA
Approved for clinical use
Skin Cancer
CAS
1195765-45-7
PubChem CID
44462760
Action
BRAF
Approved Drug List
1
Commercial Vendor
GSK